IMPACT OF LIPOFUSCIN IN RETINAL PIGMENT EPITHELIAL CELLS
脂褐质对视网膜色素上皮细胞的影响
基本信息
- 批准号:6086563
- 负责人:
- 金额:$ 25.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Verbatim from applicant's abstract): A prominent feature of aging
and of some inherited retinal degenerations is the accumulation of
autofluorescent granules of lipofuscin in retinal pigmented epithelial (RPE)
cells. Circumstantial evidence exists for an association between age-related
macular degeneration (AMD) and RPE lipofuscin; however, the impact of
lipofuscin accumulation on the RPE cell has not been directly tested. Since one
of the constituents of RPE lipofuscin, the fluorophore A2E, exhibits structural
and photodynamic properties that could be detrimental to cells, it is
hypothesized that the accumulation of this fluorophore in RPE cells plays a
role in the pathogenesis of AMD. The aim of this work is to understand the
mechanisms by which A2E forms in the RPE cell and to determine the impact of
its accumulation on the RPE cell. By high performance liquid chromatography
(HPLC) analysis, the quantities of A2E in RPE cells isolated from human eyes
will be correlated with the age, race and gender of the donors. A2E in eyes
from AMD donors will also be quantified. To develop a cell culture model of
A2E-containing cells, cultured RPE lacking endogenous A2E will be presented
with synthetic A2E in the culture media. Subsequently, the internalization of
A2E by the cells will be characterized, as will the intracellular
compartmentalization of A2E. To test the hypothesis that A2E, when present at
critical concentrations, can have adverse effects on RPE cells, the propensity
of intracellular A2E to (a) exhibit detergent-like activity, (b) damage cells
as a photosensitizing agent and (c) disrupt lysosomal function, will be
evaluated. It will also be determined whether A2E-mediated phototoxicity
involves the generation of reactive oxidant species and an apoptotic form of
RPE cell death. The ability of melanin pigment to protect against A2E-mediated
phototoxicity will also be tested. Finally, in studies related to the
biogenesis of A2E, we will obtain evidence for the formation of an intermediate
compound (A2-PE) during A2E biosynthesis. We will also address the issue of
whether A2-PE/A2E is formed in the photoreceptor outer segment membrane as
opposed to the lysosomal compartment of the RPE cell. The long-term goal of
these studies is to define conditions that accelerate the formation of A2E in
vivo and to evaluate the role of A2E in the causation of AMD. If it can be
demonstrated that the amassing of synthetic A2E by RPE cells is significant in
terms of RPE cell function, treatments could be aimed at preventing its
formation or destroying the formed molecule within the RPE cells.
描述(来自申请人摘要的逐字描述):衰老的一个显著特征
和一些遗传性视网膜变性是积累
视网膜色素上皮内脂褐素的自身荧光颗粒
细胞有间接证据表明年龄相关的
黄斑变性(AMD)和RPE脂褐素;然而,
尚未直接测试RPE细胞上的脂褐素积累。由于一个
在RPE脂褐素的成分中,荧光团A2 E具有结构
和可能对细胞有害的光动力学特性,
假设这种荧光团在RPE细胞中的积累起着重要作用,
在AMD发病机制中的作用。这项工作的目的是了解
A2 E在RPE细胞中形成的机制,并确定
它在RPE细胞上的积累。高效液相色谱
HPLC分析,从人眼分离的RPE细胞中A2 E的量
将与捐献者的年龄、种族和性别相关。A2 E眼睛
来自AMD捐赠者的捐赠也将被量化。为了建立一个细胞培养模型,
含A2 E的细胞,将呈现缺乏内源性A2 E的培养的RPE
在培养基中加入合成的A2 E。随后,
将表征细胞的A2 E,也将表征细胞内的A2 E。
A2 E的区室化。为了检验假设,A2 E,当存在于
临界浓度,可能对RPE细胞产生不利影响,
细胞内A2 E的作用,以(a)表现出洗涤剂样活性,(B)损伤细胞
作为光敏剂和(c)破坏溶酶体功能,
评估。还将确定A2 E介导的光毒性是否
涉及反应性氧化剂种类的产生和细胞凋亡形式的
RPE细胞死亡。黑色素对A2 E介导的细胞凋亡的保护作用
还将测试光毒性。最后,在与
A2 E的生物起源,我们将获得中间体形成的证据
化合物(A2-PE)在A2 E生物合成过程中。我们还将讨论
A2-PE/A2 E是否形成在感光体外节膜中,
与RPE细胞的溶酶体区室相反。的长期目标
这些研究是为了确定加速A2 E形成的条件,
目的:研究A2 E在AMD发病中的作用。如果能
证明了RPE细胞合成A2 E的积累在
就RPE细胞功能而言,治疗的目的可能是防止其
形成或破坏RPE细胞内形成的分子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Janet Ruthe Sparrow其他文献
Janet Ruthe Sparrow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Janet Ruthe Sparrow', 18)}}的其他基金
Precision genome surgery in autologous stem cell transplant
自体干细胞移植中的精准基因组手术
- 批准号:
9811117 - 财政年份:2019
- 资助金额:
$ 25.15万 - 项目类别:
Retinal Disease Promoted by Iron-Induced Bisretinoid Oxidation
铁诱导的双维A酸氧化促进视网膜疾病
- 批准号:
10402760 - 财政年份:2018
- 资助金额:
$ 25.15万 - 项目类别:
Retinal Disease Promoted by Iron-Induced Bisretinoid Oxidation
铁诱导的双维A酸氧化促进视网膜疾病
- 批准号:
10090468 - 财政年份:2018
- 资助金额:
$ 25.15万 - 项目类别:
Quantitative Fundus Autofluorescence in Retinal Disorders
视网膜疾病中的定量眼底自发荧光
- 批准号:
10358501 - 财政年份:2014
- 资助金额:
$ 25.15万 - 项目类别:
Quantitative Fundus Autofluorescence in Retinal Disorders
视网膜疾病中的定量眼底自发荧光
- 批准号:
8619402 - 财政年份:2014
- 资助金额:
$ 25.15万 - 项目类别:
Quantitative Fundus Autofluorescence in Retinal Disorders
视网膜疾病中的定量眼底自发荧光
- 批准号:
9084593 - 财政年份:2014
- 资助金额:
$ 25.15万 - 项目类别:
Imaging, Histology and Functional Diagnostics Core
影像、组织学和功能诊断核心
- 批准号:
10273969 - 财政年份:2010
- 资助金额:
$ 25.15万 - 项目类别:
Imaging, Histology and Functional Diagnostics Core
影像、组织学和功能诊断核心
- 批准号:
10475818 - 财政年份:2010
- 资助金额:
$ 25.15万 - 项目类别:
Imaging, Histology and Functional Diagnostics Core
影像、组织学和功能诊断核心
- 批准号:
10681428 - 财政年份:2010
- 资助金额:
$ 25.15万 - 项目类别:
Impact of Lipofuscin in Retinal Pigment Epithelial Cells
脂褐素对视网膜色素上皮细胞的影响
- 批准号:
7523804 - 财政年份:2000
- 资助金额:
$ 25.15万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 25.15万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
$ 25.15万 - 项目类别:














{{item.name}}会员




